KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.
Rahul Gupta, N Director of National Drug Control Policy, Office of National Drug Control Policy, disclosed 8 transactions
· Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)
2022-10-07 · purchase
Kimberly-Clark Corp. — $1,001 - $15,000
2022-09-30 · purchase
NIKE, Inc. — $1,001 - $15,000
2022-09-30 · purchase
Kimberly-Clark Corp. — $1,001 - $15,000
2022-09-29 · purchase
Kimberly-Clark Corp. — $1,001 - $15,000
2022-09-27 · purchase
Kimberly-Clark Corp. — $1,001 - $15,000
2022-09-27 · purchase
Amazon.com, Inc. — $1,001 - $15,000
2022-09-22 · purchase
Amazon.com, Inc. — $1,001 - $15,000
2022-09-14 · purchase
Kimberly-Clark Corp. — $1,001 - $15,000
The complete record
Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.
